Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
European Journal of Nuclear Medicine and Molecular Imaging
Published in: European Journal of Nuclear Medicine and Molecular Imaging 3/2016

01-03-2016 | Reply

Reply to: “Comments on Kristensen et al.: Clinical value of FDG-PET/CT in suspected paraneoplastic syndromes: a retrospective analysis of 137 patients”

By Betül Vatankulu, Sabire Yilmaz Aksoy, Sait Sager, Metin Halaç.

Authors: Stine Bjørn Kristensen, Søren Hess, Henrik Petersen, Poul Flemming Høilund-Carlsen

Published in: European Journal of Nuclear Medicine and Molecular Imaging | Issue 3/2016

Login to get access

Excerpt

Sir, …
Literature
1.
Vatankulu B, Aksoy SY, Sager S, Halaç M. Comments on Kristensen, et al. Clinical value of FDG-PET/CT in suspected paraneoplastic syndromes: a retrospective analysis of 137 patients. Eur J Nucl Med Mol Imaging. 2015. doi:10.​1007/​s00259-015-3284-2.PubMed
2.
Kristensen SB, Hess S, Petersen H, Høilund-Carlsen PF. Clinical value of FDG-PET/CT in suspected paraneoplastic syndromes: a retrospective analysis of 137 patients. Eur J Nucl Med Mol Imaging. 2015;42:2056–63.PubMedCrossRef
3.
Vatankulu B, Yilmaz Aksoy S, Asa S, Sager S, Sayman HB, Halac M, et al. Accuracy of FDG-PET/CT and paraneoplastic antibodies in diagnosing cancer in paraneoplastic neurological syndromes. Rev Esp Med Nucl Imagen Mol. 2015. doi:10.​1016/​j.​remn.​2015.​07.​001.
Metadata
Title
Reply to: “Comments on Kristensen et al.: Clinical value of FDG-PET/CT in suspected paraneoplastic syndromes: a retrospective analysis of 137 patients”
By Betül Vatankulu, Sabire Yilmaz Aksoy, Sait Sager, Metin Halaç.
Authors
Stine Bjørn Kristensen
Søren Hess
Henrik Petersen
Poul Flemming Høilund-Carlsen
Publication date
01-03-2016
Publisher
Springer Berlin Heidelberg
Published in
European Journal of Nuclear Medicine and Molecular Imaging / Issue 3/2016
Print ISSN: 1619-7070
Electronic ISSN: 1619-7089
DOI
https://doi.org/10.1007/s00259-015-3283-3

Other articles of this Issue 3/2016

European Journal of Nuclear Medicine and Molecular Imaging 3/2016 Go to the issue

Editorial Commentary

68Ga-PSMA-HBED-CC PET/CT: where molecular imaging has an edge over morphological imaging

Review Article

Clinical impact of 99mTc-MAA SPECT/CT-based dosimetry in the radioembolization of liver malignancies with 90Y-loaded microspheres

Reply

Reply to the letter of Zattoni et al.

Society Communications

Svetlana Miceva Ristevska—an obituary

Editorial

Radiopharmaceuticals in paraganglioma imaging: too many members on board?

Letter to the Editor

Comments on Kristensen et al.: Clinical value of FDG-PET/CT in suspected paraneoplastic syndromes: a retrospective analysis of 137 patients